Nanomedicine or nano-therapeutics is the result of application of nanotechnology in the medical field. Nanomedicines range from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even biological machines (a promising future application of molecular nanotechnology). Nanomedicines find applications in monitoring, construction, repair, and control of human biological systems at the molecular level, by the use of nanodevices and nanostructures.
Portland, OR -- (SBWIRE) -- 07/26/2017 -- The global nanomedicines market is driven by increase in prevalence of chronic disorders, presence of high, unmet medical needs (especially in developing countries), and increase in government funding for nanomedicines. However, lack of organized regulatory standards restrains the market growth. The growth opportunities in the emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.
Get sample copy of the report at: https://www.alliedmarketresearch.com/request-toc-and-sample/2021
The report segments the market based on product, application, and geography. Based on product, the market is divided into therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. Nanomedicines find application in the fields of oncology, cardiology, neurology, orthopedics, anti-inflammatory, anti-infectives, infectious diseases, and other chronic abnormalities. Geographically, the market is analyzed across North America (U.S., Canada, and Mexico); Europe (Germany, France, Italy, UK, Spain, and rest of Europe); Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific); and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major companies profiled in the report include CombiMatrix Corporation, Abbott Laboratories, Celgene Corporation, Mallinckrodt plc, Johnson & Johnson, Merck & Co. Inc., General Electric Company, Pfizer Inc., Nanosphere Inc., and Teva Pharmaceutical Industries Ltd.
For more info, connect to our analyst at: https://www.alliedmarketresearch.com/connect-to-analyst/2021
Nanomedicine Market Key Segments:
By Product
- Therapeutics
- Regenerative Medicine
- In-vitro Diagnostics
- In-vivo Diagnostics
- Vaccines
By Application
- Oncology
- Cardiology
- Neurology
- Orthopedics
- Anti-inflammatory
- Anti-infectives
- Infectious Diseases
- Others
By Region
- North America
- Europe
- Asia-Pacific
- LAMEA